Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Olive

Showing results (271-280 of 305) with videos related to

Pageof 31
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric OncologyM F Tournade, J Lemerle, M Brunat-Mentigny, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Leukemia|July 1, 1994
Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2D Olive, H Chambost, D Sainty, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
British Journal of Haematology|July 1, 1993
A tumour-associated antigen expression in human haematological malignanciesH Chambost, F Brasseur, P Coulie, et al.
Blood|December 12, 2001
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairmentM Mohty, D Jarrossay, M Lafage-Pochitaloff, et al.
Infection|October 26, 2012
Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infectionsY Maaloum, A Meybeck, D Olive, et al.
Bone Marrow Transplantation|March 1, 1989
Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adultsD Maraninchi, C Mawas, A M Stoppa, et al.
Molecular Immunology|February 1, 1996
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesisA Truneh, M Reddy, P Ryan, et al.
Pageof 31

Showing results (271-280 of 305) with videos related to

Sort By:
Pageof 31
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1988
Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric OncologyM F Tournade, J Lemerle, M Brunat-Mentigny, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|April 1, 1992
Interleukin-2 in association with increasing doses of interferon-gamma in patients with advanced cancerP Viens, D Blaise, A M Stoppa, et al.
Bone Marrow Transplantation|August 1, 1991
Prevention of acute GVHD by in vivo use of anti-interleukin-2 receptor monoclonal antibody (33B3.1): a feasibility trial in 15 patientsD Blaise, D Olive, M Hirn, et al.
Leukemia|July 1, 1994
Modifications of leukemic blast cells induced by in vivo high-dose recombinant interleukin-2D Olive, H Chambost, D Sainty, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 1, 1991
Anti-LFA1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host diseaseA M Stoppa, D Maraninchi, D Blaise, et al.
British Journal of Haematology|July 1, 1993
A tumour-associated antigen expression in human haematological malignanciesH Chambost, F Brasseur, P Coulie, et al.
Blood|December 12, 2001
Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairmentM Mohty, D Jarrossay, M Lafage-Pochitaloff, et al.
Infection|October 26, 2012
Clinical spectrum and outcome of critically ill patients suffering from prosthetic joint infectionsY Maaloum, A Meybeck, D Olive, et al.
Bone Marrow Transplantation|March 1, 1989
Anti LFA1 monoclonal antibody for the prevention of graft rejection after T cell-depleted HLA-matched bone marrow transplantation for leukemia in adultsD Maraninchi, C Mawas, A M Stoppa, et al.
Molecular Immunology|February 1, 1996
Differential recognition by CD28 of its cognate counter receptors CD80 (B7.1) and B70 (B7.2): analysis by site directed mutagenesisA Truneh, M Reddy, P Ryan, et al.
Pageof 31